MXPA03000188A - Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales. - Google Patents

Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.

Info

Publication number
MXPA03000188A
MXPA03000188A MXPA03000188A MXPA03000188A MXPA03000188A MX PA03000188 A MXPA03000188 A MX PA03000188A MX PA03000188 A MXPA03000188 A MX PA03000188A MX PA03000188 A MXPA03000188 A MX PA03000188A MX PA03000188 A MXPA03000188 A MX PA03000188A
Authority
MX
Mexico
Prior art keywords
methods
related diseases
topical anesthetics
treating neutrophil
neutrophil
Prior art date
Application number
MXPA03000188A
Other languages
English (en)
Inventor
Loren W Hunt
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Publication of MXPA03000188A publication Critical patent/MXPA03000188A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MXPA03000188A 2000-06-23 2001-06-22 Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales. MXPA03000188A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21403100P 2000-06-23 2000-06-23
PCT/US2001/019977 WO2002000218A2 (en) 2000-06-23 2001-06-22 Methods of treating neutrophil-related diseases with topical anesthetics

Publications (1)

Publication Number Publication Date
MXPA03000188A true MXPA03000188A (es) 2003-09-22

Family

ID=22797503

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000188A MXPA03000188A (es) 2000-06-23 2001-06-22 Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.

Country Status (9)

Country Link
US (4) US6861449B2 (es)
EP (1) EP1296683A2 (es)
JP (1) JP2004501193A (es)
AU (2) AU2001271386B2 (es)
CA (1) CA2414389A1 (es)
IL (1) IL153574A0 (es)
MX (1) MXPA03000188A (es)
NO (1) NO20026222L (es)
WO (1) WO2002000218A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1296683A2 (en) * 2000-06-23 2003-04-02 Mayo Foundation For Medical Education And Research Methods of treating neutrophil-related diseases with topical anesthetics
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US6861499B2 (en) * 2003-02-24 2005-03-01 Triton Systems, Inc. Branched polyphosphonates that exhibit an advantageous combination of properties, and methods related thereto
WO2005060640A2 (en) * 2003-12-15 2005-07-07 Sarnoff Corporation Method and apparatus for object tracking prior to imminent collision detection
US7452524B2 (en) 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
US7452523B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
US20060062739A1 (en) * 2004-09-20 2006-03-23 Thomas Hofmann Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients
EP1807123A4 (en) * 2004-09-20 2010-01-13 Gilead Sciences Inc METHOD FOR IMPROVING TOLERANCE ON THERAPEUTICALLY EFFECTIVE MEANS THROUGH INHALATION
EP1824466A4 (en) * 2004-12-16 2008-03-05 Advanced Inhalation Res Inc COMPOSITIONS AND METHODS FOR TREATING PULMONARY DISORDERS
JP2008532493A (ja) * 2005-02-14 2008-08-21 ワイス Ｉｌ−１７ｆとｉｌ−１７ｒとの間の相互作用の特性解析
EP2101819B1 (en) 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis
CN102725401A (zh) 2009-07-10 2012-10-10 哈佛大学校长及研究员协会 作为抗炎药的永久带电荷的钠和钙通道阻断剂
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022527690A (ja) 2019-03-11 2022-06-03 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3170070A1 (en) 2020-03-11 2021-09-16 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
NL2025253B1 (en) * 2020-03-31 2021-10-22 Hasan Djohan Use of lidocaine in treatment of respiratory diseases
AU2021248263A1 (en) * 2020-03-31 2022-11-03 Nomoreitis B.V. Treatment of hyperinflammatory syndrome
CN113764038B (zh) * 2021-08-31 2023-08-22 华南理工大学 构建骨髓增生异常综合征转白基因预测模型的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
US5510339A (en) * 1993-02-02 1996-04-23 Mayo Foundation For Medical Education And Research Method for the treatment of bronchial asthma by administration of topical anesthetics
BR9911094A (pt) * 1998-06-09 2001-10-30 Nortran Pharmaceuticals Inc Composições e métodos para o tratamento detosse
EP1296683A2 (en) * 2000-06-23 2003-04-02 Mayo Foundation For Medical Education And Research Methods of treating neutrophil-related diseases with topical anesthetics

Also Published As

Publication number Publication date
IL153574A0 (en) 2003-07-06
EP1296683A2 (en) 2003-04-02
US20060100276A1 (en) 2006-05-11
AU7138601A (en) 2002-01-08
WO2002000218A3 (en) 2002-05-16
US20030171402A1 (en) 2003-09-11
JP2004501193A (ja) 2004-01-15
AU2001271386B2 (en) 2005-04-07
NO20026222D0 (no) 2002-12-23
CA2414389A1 (en) 2002-01-03
US20090054485A1 (en) 2009-02-26
US6861449B2 (en) 2005-03-01
WO2002000218A2 (en) 2002-01-03
US7816374B2 (en) 2010-10-19
US20040077717A1 (en) 2004-04-22
NO20026222L (no) 2003-02-20

Similar Documents

Publication Publication Date Title
MXPA03000188A (es) Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
IL162533A0 (en) Chalcone derivatives and their use to treat diseases
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2002231039A1 (en) Therapeutic stockings
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
GB0028429D0 (en) Therapy
AU2002343739A1 (en) Improved therapy for topical diseases
AUPQ877300A0 (en) Topical treatment of skin
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
MXPA03008634A (es) Nuevos compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades.
PL354110A1 (en) Combined therapy for treating the both alcoholism and alcohol dependence
GB0004531D0 (en) The treatment of respiratory diseases
AU2001227972A1 (en) Methods to treat alpha-1-antitrypsin deficiency
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
GB0001710D0 (en) Therapeutic treatment
IL150479A0 (en) Treatment of psoriasis
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU2002216758A1 (en) Quinazolines with therapeutic use
AU2096002A (en) Therapeutic treatment
AU2001261324A1 (en) Psoriasis treatment
GB0029524D0 (en) Disease treatment
AU2001289127A1 (en) Tumor treatment
HUP0302882A3 (en) Improved specificity in treatment of diseases
ZA200205415B (en) Novel therapeutic use of enoxaparin.